Global CVD leaders call the world to action—25 by 2025—from the World Congress of Cardiology

April 23, 2012 in Cardiology

The Global Cardiovascular Disease Taskforce called on the 11,000 World Congress of Cardiology delegates in Dubai, and the cardiovascular disease (CVD) community at large, to support the adoption of a global goal to reduce premature non-communicable disease (NCD) mortality by 25 per cent by 2025. The Task Force which is made up of leadership from the world's largest CVD organizations including the American Heart Association, American College of Cardiology, European Heart Network, European Society of Cardiology and the World Heart Federation is committed to reducing the global burden of CVD.

As the leading cause of worldwide, NCDs are responsible for more than 36 million deaths each year. Nearly half of these – 17.3 million – are due to CVD, a number that fails to fully reflect the social and economic impact on families, communities and countries. Yet NCDs and CVD specifically, continues to be viewed as a "lifestyle" disease primarily afflicting those in high-income countries. In fact, the greatest CVD burden falls on low- and middle-income countries where 80% of all CVD deaths occur and is increasingly impacting people during their most productive years. The enormous human and financial cost associated with CVD led to a joint CVD effort to bring CVD and other NCDs to the attention of global leaders outside of the traditional health sector.

This call was answered in September 2011 when world leaders gathered for the second ever United Nations High-level Meeting on a health issue, to discuss the growing epidemic of NCDs and make a concerted commitment to halt and reverse the NCD burden. Formalized in a Political Declaration on NCDs, governments made a set of commitments to reduce this burden through a comprehensive framework inclusive of global targets.

"The set of global targets and indicators to be reviewed and potentially adopted at the World Health Assembly – the annual General Meeting of the World Health Organization in Geneva – is the first and most important step in creating global change," said CEO, Nancy Brown. member and President of the World Heart Federation Professor Sidney C. Smith Jr., continued: "The Global CVD Taskforce strongly supports keeping the first target of reducing premature NCD 25 percent by 2025 and are aligning with the broader NCD community in renaming it an overarching goal. A global mortality goal will provide a shared vision of NCDs for all stakeholders and ensure that the world works together to address this global burden."

Under the direction of the WHO, relevant stakeholders, including non-governmental organizations (NGOs) and governments, were invited to comment up until 19 April on these proposed targets. "With CVD as the largest single contributor to global mortality and accounting for nearly half of the 36 million NCD deaths, achieving these goals will require partnerships at all levels" stated David Wood of the . "We have the opportunity of a lifetime to make meaningful change in our home, country, and in the world by calling for the global target, or goal, of a 25 per cent reduction in premature NCD mortality by 2025."

"The truly devastating impact of cardiovascular diseases to families and economies, requires immediate action on the part of all stakeholders – most notably the World Health Organization" said Dr William Zoghbi, President of the American College of Cardiology.

"Health is central to a country's economic growth" says Dr Hans Stam, President of the European Heart Network, "and its significance in sustainable development can no longer be ignored. Health cannot be neglected and it is our hope that Member States answer this call."

Provided by World Heart Federation

not rated yet  

Rank not rated yet
Relevant PhysicsForums posts

More news stories

Costs to treat stroke in America may double by 2030

Costs to treat stroke are projected to more than double and the number of people having strokes may increase 20 percent by 2030, according to the American Heart Association/American Stroke Association.

Cardiology created 6 hours ago | popularity not rated yet | comments 0

New blood-thinner measures may cut medication errors

Blood thinners are the preferred treatment option to prevent heart attacks, blood clots and stroke, but they are not without risk, and not just because of their side effects. These high-risk drugs, known as anticoagulants, ...

Cardiology created 9 hours ago | popularity not rated yet | comments 0

Registry questions superiority of bivalirudin over heparin

Results from a large observational study reported at EuroPCR 2013 today question whether bivalirudin is superior to heparin in the absence of GPIIb/IIIa blockade, showing similar 30-day mortality in patients with non-ST segment ...

Cardiology created 9 hours ago | popularity not rated yet | comments 0

Study shows low rate of late lumen loss with bioresorbable DESolve device

The DESolve bioresorbable coronary scaffold system achieves good efficacy and safety with low rates of late lumen loss and major coronary adverse events at six months, show first results from the pivotal DESolve Nx trial ...

Cardiology created 9 hours ago | popularity not rated yet | comments 0

Biodegradable stent proves non-inferior to drug-eluting stent

The Orsiro stent, which is a novel stent platform eluting sirolimus from a biodegradable polymer, demonstrated non-inferiority to the Xience Prime everolimus-eluting stent for the primary angiographic endpoint of in-stent ...

Cardiology created May 21, 2013 | popularity 5 / 5 (1) | comments 0


Fecal microbiota tx feasible for recurrent C. difficile in HIV

(HealthDay)—For HIV-infected individuals with recurrent Clostridium difficile infection, fecal microbiota therapy is feasible, according to a letter published in the May 21 issue of the Annals of Intern ...

FDA panel backs experimental Merck insomnia drug

(AP)—A federal panel of medical experts says that an experimental insomnia drug from Merck & Co Inc. appears safe and effective, despite evidence from company trials that the pill can cause daytime sleepiness and difficulty ...

Having both migraines, depression may mean smaller brain

(HealthDay)—Migraines and depression can each cause a great deal of suffering, but new research indicates the combination of the two may be linked to something else entirely—a smaller brain.

Systematic screening of med adherence will ID barriers

(HealthDay)—Implementation of systematic monitoring for medication adherence will allow for identification of barriers to adherence and tailoring of interventions, according to a viewpoint piece published ...

Brain can be trained in compassion, study shows

Until now, little was scientifically known about the human potential to cultivate compassion—the emotional state of caring for people who are suffering in a way that motivates altruistic behavior.

Slowing the aging process—only with antibiotics

Swiss scientists reveal the mechanism responsible for aging hidden deep within mitochondria—and dramatically slow it down in worms by administering antibiotics to the young.